EUVIMEDEUVIMED entdecken
Leitlinie

Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of microscopic polyangiitis and granulomatosis with polyangiitis: The 2023 update – secondary publication

Ken-Ei Sada iD, Kenji Nagasaka, Shinya Kaname, Eishu Nango, Kan Kishibe, Hiroaki Dobashi, Keiju Hiromura, Tamihiro Kawakami, Masashi Bando, Takashi Wada, Koichi Amano, Yohko Murakawa und 1 weitere

Modern Rheumatology · 28.03.2024 · 34 (3) · 559-567

DOI: 10.1093/mr/road081 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Modern Rheumatology, online erschienen am 28.07.2023. Verfasst von Ken-Ei Sada und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Ome Municipal General Hospital, Ome, Japan. Hauptthemen laut MEDLINE: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Granulomatosis with Polyangiitis, Microscopic Polyangiitis. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To revise the 2017 clinical practice guidelines (CPG) for the management of microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA) to reflect advancements in the field.

Methods

Similar to the 2017 CPG, the Grading of Recommendations, Assessment, Development, and Evaluation system was adopted for this revision. The intended users of this CPG include patients diagnosed with MPA or GPA in Japan and their families and healthcare professionals, including specialists and non-specialists. Based on a scoping review, four clinical questions (CQs) of the 2017 guidelines were modified, and six new CQs were added.

Results

We suggest a combination of glucocorticoid and cyclophosphamide or rituximab for remission induction therapy. In cases where cyclophosphamide or rituximab is used, we suggest the use of avacopan over high-dose glucocorticoid. Furthermore, we suggest against the use of plasma exchange in addition to the standard treatment in severe cases of MPA/GPA. Finally, we suggest the use of glucocorticoid and rituximab over glucocorticoid and azathioprine for remission maintenance therapy.

Conclusions

The recommendations have been updated based on patient preference, certainty of evidence, benefit and risk balance, and cost.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisGranulomatosis with PolyangiitisMicroscopic PolyangiitisHumansAntibodies, Antineutrophil CytoplasmicCyclophosphamideGlucocorticoidsImmunosuppressive AgentsJapanRituximab

Stichwörter der Autor:innen

ANCA-associated vasculitisclinical practice guidelinegrading of recommendations, assessment, development, and evaluation systemgranulomatosis with polyangiitismicroscopic polyangiitis

Substanzen

Antibodies, Antineutrophil CytoplasmicCyclophosphamideGlucocorticoidsImmunosuppressive AgentsRituximab

Autor:innen und Institutionen

  • Department of Rheumatology, Ome Municipal General Hospital, Ome, Japan.
  • Department of Rheumatology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Department of Nephrology and Rheumatology, Kyorin University School of Medicine, Tokyo, Japan.
  • Department of Family Medicine, Seibo International Catholic Hospital, Tokyo, Japan.
  • Department of Otolaryngology-Head & Neck Surgery, Asahikawa Medical University, Asahikawa, Japan.
  • Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan.

ORCID-Profile: Ken-Ei Sada

Zitieren

APA

Sada, K. E., Nagasaka, K., Kaname, S., Nango, E., Kishibe, K., Dobashi, H., Hiromura, K., Kawakami, T., Bando, M., Wada, T., Amano, K., Murakawa, Y., & Harigai, M. (2024). Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of microscopic polyangiitis and granulomatosis with polyangiitis: The 2023 update – secondary publication. Modern Rheumatology, 34(3), 559-567. https://doi.org/10.1093/mr/road081

Vancouver

Sada KE, Nagasaka K, Kaname S, Nango E, Kishibe K, Dobashi H, et al. Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of microscopic polyangiitis and granulomatosis with polyangiitis: The 2023 update – secondary publication. Modern Rheumatology. 2024;34(3):559-567. doi:10.1093/mr/road081

BibTeX
@article{Sada2024,
  author = {Sada, Ken-Ei and Nagasaka, Kenji and Kaname, Shinya and Nango, Eishu and Kishibe, Kan and Dobashi, Hiroaki and Hiromura, Keiju and Kawakami, Tamihiro and Bando, Masashi and Wada, Takashi and Amano, Koichi and Murakawa, Yohko and Harigai, Masayoshi},
  title = {Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of microscopic polyangiitis and granulomatosis with polyangiitis: The 2023 update – secondary publication},
  journal = {Modern Rheumatology},
  year = {2024},
  volume = {34},
  number = {3},
  pages = {559--567},
  doi = {10.1093/mr/road081}
}
Kostenlos starten →